Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes

Molecules

Volumn 16, Issue 9, 2011, Pages 7210-7223

  Katsumata, Kiyomitsu ^a   Chono, Koji ^a   Sudo, Kenji ^a   Shimizu, Yasuaki ^a   Kontani, Toru ^a   Suzuki, Hiroshi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Amenamevir; Antiviral; ASP2151; Genital herpes; Guinea pig; HSV

Indexed keywords

ACICLOVIR; AMENAMEVIR; ANTIVIRUS AGENT; DNA PRIMASE; DRUG DERIVATIVE; HELICASE; HELICASE PRIMASE, HUMAN HERPESVIRUS 1; HELICASE-PRIMASE, HUMAN HERPESVIRUS 1; OXADIAZOLE DERIVATIVE; VALACICLOVIR; VALINE; VIRUS PROTEIN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENITAL HERPES; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; VIROLOGY; VIRUS CULTURE; VIRUS LOAD; VIRUS SHEDDING;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; AREA UNDER CURVE; DNA HELICASES; DNA PRIMASE; DRUG EVALUATION, PRECLINICAL; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; OXADIAZOLES; VALINE; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRAL PROTEINS; VIRUS SHEDDING;

EID: 80053270816     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16097210     Document Type: Article

References (42)

1. Pellet, P.E.; Roizman, B. The family Herpesviridae: A brief introduction. In Fields Virology, 5th ed.; Knipe, D., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2479-2499.
2. Benedetti, J.; Corey, L.; Ashley, R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 1994, 121, 847-854.
3. Kinghorn, G.R. Epidemiology of genital herpes. J. Int. Med. Res. 1994, 22 (Suppl. 1), 14A-23A. (Pubitemid 24169788)
4. Whitley, R.J.; Roizman, B. Herpes simplex virus infections. Lancet 2001, 357, 1513-1518. (Pubitemid 32488876)
5. Ashley, R.L.; Wald, A. Genital herpes: Review of the epidemic and potential use of type-specific serology. Clin. Microbiol. Rev. 1999, 12, 1-8. (Pubitemid 29055950)
6. Whitley, R.J.; Kimberlin, D.W.; Roizman, B. Herpes simplex viruses. Clin. Infect. Dis. 1998, 26, 541-553.
7. Lafferty, W.E. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing. Herpes 2002, 9, 51-55. (Pubitemid 37486609)
8. Wald, A.; Zeh, J.; Selke, S.; Ashley, R.L.; Corey, L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 1995, 333, 770-775.
9. Lafferty, W.E.; Coombs, R.W.; Benedetti, J.; Critchlow, C.; Corey, L. Recurrences after oral and genital herpes simplex virus infection. N. Engl. J. Med. 1987, 316, 1444-1449.
10. Engelberg, R.; Carrell, D.; Krantz, E.; Corey, L.; Wald, A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm. Dis. 2003, 30, 174-177. (Pubitemid 36184367)
11. De Clercq, E. Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemother. 1993, 32 (Suppl. A), 121-132. (Pubitemid 23244716)
12. De Clercq, E.; Field, H.J. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol. 2006, 147, 1-11. (Pubitemid 43069091)
13. Crumpacker, C.S.; Schaffer, P.A. New anti-HSV therapeutics target the helicase-primase complex. Nat. Med. 2002, 8, 327-328. (Pubitemid 34407020)
14. Reichman, R.C.; Badger, G.J.; Mertz, G.J.; Corey, L.; Richman, D.D.; Connor, J.D.; Redfield, D.; Savoia, M.C.; Oxman, M.N.; Bryson, Y.; Tyrrell, D.L.; Portnoy, J.; Creigh-Kirk, T.; Keeney, R.E.; Ashikaga, T.; Dolin, R. Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. JAMA 1984, 251, 2103-2107. (Pubitemid 14133504)
15. Spruance, S.L.; Stewart, J.C.; Rowe, N.H.; McKeough, M.B.; Wenerstrom, G.; Freeman, D.J. Treatment of recurrent herpes simplex labialis with oral acyclovir. J. Infect. Dis. 1990, 161, 185-190. (Pubitemid 20056644)
16. Chono, K.; Katsumata, K.; Kontani, T.; Kobayashi, M.; Sudo, K.; Yokota, T.; Konno, K.; Shimizu, Y.; Suzuki, H. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. J. Antimicrob. Chemother. 2010, 65, 1733-1741.
17. Crute, J.J.; Grygon, C.A.; Hargrave, K.D.; Simoneau, B.; Faucher, A.M.; Bolger, G.; Kibler, P.; Liuzzi, M.; Cordingley, M.G. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat. Med. 2002, 8, 386-391. (Pubitemid 34407034)
18. Kleymann, G.; Fischer, R.; Betz, U.A.; Hendrix, M.; Bender, W.; Schneider, U.; Handke, G.; Eckenberg, P.; Hewlett, G.; Pevzner, V.; Baumeister, J.; Weber, O.; Henninger, K.; Keldenich, J.; Jensen, A.; Kolb, J.; Bach, U.; Popp, A.; Maben, J.; Frappa, I.; Haebich, D.; Lockhoff, O.; Rubsamen-Waigmann, H. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med. 2002, 8, 392-398. (Pubitemid 34407035)
19. Baumeister, J.; Fischer, R.; Eckenberg, P.; Henninger, K.; Ruebsamen-Waigmann, H.; Kleymann, G.; Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease. Antiviral Chem. Chemother. 2007, 18, 35-48. (Pubitemid 46426936)
20. Betz, U.A.K.; Fischer, R.; Kleymann, G.; Hendrix, M.; Rubsamen-Waigmann, H. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrob. Agents Chemother. 2002, 46, 1766-1772. (Pubitemid 34535195)
21. Lucas, B.A.; Wiesendanger, W.; Schmidt-Ruppin, K.H. Genital herpres in guinea pigs. Archives Virol. 1974, 44, 153-155.
22. Whitley, R.J. Herpes simplex viruses. In Fields Virology, 5th ed.; Knipe, D., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2501-2601.
23. Landry, M.L.; Myerson, D.; Bull, C. Recurrent genital infection in the guinea pig: differences between herpes simplex types 1 and 2. Intervirology 1992, 34, 169-179. (Pubitemid 23191271)
24. Stanberry, L.R. Animal-models and HSV latency. Semin. Virol. 1994, 5, 213-219.
25. Stanberry, L.R.; Kern, E.R.; Richards, J.T.; Abbott, T.M.; Overall, J.C., Jr. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J. Infect. Dis. 1982, 146, 397-404. (Pubitemid 12031217)
26. Stanberry, L.R.; Kit, S.; Myers, M.G. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J. Virol. 1985, 55, 322-328. (Pubitemid 16239717)
27. Stanberry, L.R.; Kern, E.R.; Richards, J.T.; Overall, J.C., Jr., Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology 1985, 24, 226-231. (Pubitemid 16210922)
28. Bourne, N.; Ireland, J.; Stanberry, L.R.; Bernstein, D.I. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs. Antiviral Res. 1999, 40, 139-144. (Pubitemid 29073317)
29. Bernstein, D.I.; Harrison, C.J.; Tomai, M.A.; Miller, R.L. Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J. Infect Dis. 2001, 183, 844-849. (Pubitemid 32207051)
30. Bourne, N.; Bravo, F.J.; Ashton, W.T.; Meurer, L.C.; Tolman, R.L.; Karkas, J.D.; Stanberry, L.R. Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes. Antimicrob. Agents Chemother. 1992, 36, 2020-2024.
31. Bravo, F.J.; Stanberry, L.R.; Kier, A.B.; Vogt, P.E.; Kern, E.R. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs. Antiviral Res. 1993, 21, 59-72. (Pubitemid 23119402)
32. Jennings, R.; Smith, T.L.; Myhren, F.; Phillips, J.; Sandvold, M.L. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes. Antimicrob. Agents Chemother. 1999, 43, 53-61. (Pubitemid 29069199)
33. Rose, W.A., II; Tuthill, C.; Pyles, R.B. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2). Int. J. Antimicrob. Agents 2008, 32, 262-266.
34. Miller, R.L.; Imbertson, L.M.; Reiter, M.J.; Gerster, J.F. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod. Antiviral Res. 1999, 44, 31-42. (Pubitemid 29505329)
35. Landry, M.L.; Lucia, H.L.; Hsiung, G.D.; Pronovost, A.D.; Dann, P.R.; August, M.J.; Mayo, D.R. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig. Am. J. Med. 1982, 73, 143-150. (Pubitemid 12067774)
36. Pronovost, A.D.; Lucia, H.L.; Dann, P.R.; Hsiung, G.D. Effect of acyclovir on genital herpes in guinea pigs. J. Infect. Dis. 1982, 145, 904-908. (Pubitemid 12088971)
37. Myerson, D.; Hsiung, G.D. Prophylactic and therapeutic treatment with acyclovir of genital herpes in the guinea pig. Proc. Soc. Exp. Biol. Med. 1983, 174, 147-152. (Pubitemid 14228174)
38. Corey, L.; Wald, A.; Patel, R.; Sacks, S.L.; Tyring, S.K.; Warren, T.; Douglas, J.M.; Paavonen, J.; Morrow, R.A.; Beutner, K.R.; Stratchounsky, L.S.; Mertz, G.; Keene, O.N.; Watson, H.A.; Tait, D.; Vargas-Cortes, M.; Stud, V.H.T. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 2004, 350, 11-20. (Pubitemid 38032179)
39. Wald, A.; Corey, L.; Cone, R.; Hobson, A.; Davis, G.; Zeh, J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 1997, 99, 1092-1097. (Pubitemid 27123647)
40. Gupta, R.; Wald, A.; Krantz, E.; Selke, S.; Warren, T.; Vargas-Cortes, M.; Miller, G.; Corey, L. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J. Infect. Dis. 2004, 190, 1374-1381. (Pubitemid 39332176)
41. Kern, E.R. Acyclovir treatment of experimental genital herpes simplex virus infections. Am. J. Med. 1982, 73, 100-108. (Pubitemid 12067767)
42. De Clercq, E.; Descamps, J.; Ogata, M.; Shigeta, S. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. Antimicrob. Agents. Chemother. 1982, 21, 33-38. (Pubitemid 12189469)